Business Bites: Thoratec and Abiomed make bolt-ons; T2 plans $69m IPO
This article was originally published in Clinica
Executive Summary
Two heart pump specialists have made small bolt-on acquisitions, with Thoratec scooping up Apica Cardiovascular for $35m (and up to $40m in milestones), and Abiomed acquiring German firm Entwicklungsgesellschaft or ECP for around $13m upfront.